Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005815
Status:
COMPLETED
Last Update Posted:
2013-06-19
First Post:
2000-06-02
Brief Title:
Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-12
Start Date Type:
None
Primary Completion Date:
2004-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-08
Completion Date Type:
ACTUAL
First Submit Date:
2000-06-02
First Submit QC Date:
January 26 2003
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-17
Last Update Post Date:
2013-06-19
Last Update Post Date Type:
ESTIMATED